Venus Remedies surges 6% after getting marketing nod for lung cancer drug
Venus Remedies share price hit an intraday high of Rs 355 per share, rising 6 per cent on the BSE in Monday's intraday trade ...
moneycontrol.com5 天
Venus Remedies bags Marketing Authorization in the Philippines for Chemotherapy agent
Pharma company Venus Remedies bagged a Marketing Authorization nod in the Philippines for Pemetrexed 500mg, an agent used in Chemotherapy while treating lung cancer, sending the share price sharply ...
cnbctv185 天
Venus Remedies surges nearly 8% on authorisation to market lung cancer treatment drug in ...
Venus Remedies informed the exchanges on December 6 that it has received the marketing authorisation for Pemetrexed 500mg, a ...
manilatimes25 天
Junshi Biosciences Announces UK MHRA Approval for Marketing of Toripalimab
SHANGHAI, Nov. 16, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the ...